J-STAR Research, Inc.: Process Improvements Supporting Preclinical and Phase 1 Programs. | CPhI North America

CPhI North America is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

 

View, browse and sort the ever-growing list of sessions by pass type, track, and format. With this Session Scheduler, you can build your schedule in advance and access it during the show via export or with the Mobile App, once live. Sessions do fill up and seating is first come, first serve, so arrive early to sessions that you would like to attend.

J-STAR Research, Inc.: Process Improvements Supporting Preclinical and Phase 1 Programs.

Dr. Andrew Thompson (President & CEO, J-STAR Research, Inc.)

Location: Exhibitor Showcase Theater

Date: Tuesday, April 30

Time: 1:00pm - 1:25pm

Track: Exhibitor Showcase

Vault Recording: TBD

J-STAR Research is world renowned for providing process research capabilities supporting small molecule preclinical and Phase-1 development programs. The company has worked with hundreds of biotechnology and emerging pharmaceutical companies over the past twenty years. Most recently, J-STAR has expanded it’s capabilities to now provide process support in the following areas: crystallization, single crystal x-ray and catalyst screening. This talk will focus on how these added capabilities have been able to help drive and assist our process chemists in developing an optimal process supporting API development programs for our clients.